AKT1 and cancer: Inhibitors of the Akt pathway have been shown to increase the radiosensitivity of human cancer cell lines (Martelli et al, 2003; Kim et al, 2005; Li et al, 2009; Chautard et al, 2010; Connolly et al, 2012).